Qing-bo Wang
Kunming, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Reconsidering vascular invasion terminology in hepatocellular carcinoma staging: implications for accurate prognosis and treatment.
Journal: Journal of the National Cancer Center
Published: November 02, 2025
Prognostic value of lymphatic vessel density in the capsule of early-stage hepatocellular carcinoma: implications for postoperative recurrence risk.
Journal: Frontiers in immunology
Published: September 27, 2025
Impact of Middle Hepatic Vein Resection During Hemihepatectomy on Surgical Outcomes and Long-Term Prognosis in Hepatocellular Carcinoma: A Retrospective Study.
Journal: Journal of hepatocellular carcinoma
Published: July 26, 2025
Tumor Compression of the Hepatic or Portal Vein Predicts the Presence of Microvascular Invasion and Satellite Nodules in Hepatocellular Carcinoma: A Retrospective Study.
Journal: Journal of hepatocellular carcinoma
Published: June 05, 2025
The effectiveness and safety of therapies for hepatocellular carcinoma with tumor thrombus in the hepatic vein, inferior vena cave and/or right atrium: a systematic review and single-arm meta-analysis.
Journal: Expert review of anticancer therapy
Published: April 04, 2025
Activation of lymphangiogenesis by platelet as novel therapeutic approaches for liver cirrhosis and portal hypertension.
Journal: World journal of gastroenterology
Published: March 27, 2025
Tumor-associated lymphatic vessel density is a postoperative prognostic biomarker of hepatobiliary cancers: a systematic review and meta-analysis.
Journal: Frontiers in immunology
Published: October 30, 2024
Tumor-associated lymphatic vessel density is a reliable biomarker for prognosis of esophageal cancer after radical resection: a systemic review and meta-analysis.
Journal: Frontiers in immunology
Published: June 23, 2024
Portal Venous and Hepatic Arterial Coefficients Predict Post-Hepatectomy Overall and Recurrence-Free Survival in Patients with Hepatocellular Carcinoma: A Retrospective Study.
Journal: Journal of hepatocellular carcinoma
Published: January 31, 2024
Brucine suppresses proliferation and promotes apoptosis of human cholangiacarcinoma cells via the inhibition of COX2 expression.
Journal: Journal of Cancer
Published: June 27, 2023
Showing 1-11 of 11
Last Updated: 09/26/2026